z-logo
open-access-imgOpen Access
Clinical experience and critical evaluation of the role of everolimus in advanced renal cell carcinoma
Author(s) -
Pierre I. Karakiewicz,
Sun,
Firas Abdollah,
Jan Schmitges,
Claudio Jeldres,
Shahrokh F. Shariat,
Perrotte
Publication year - 2011
Publication title -
research and reports in urology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.506
H-Index - 20
ISSN - 2253-2447
DOI - 10.2147/rru.s13283
Subject(s) - everolimus , medicine , renal cell carcinoma , hazard ratio , discontinuation , placebo , adverse effect , oncology , population , targeted therapy , cancer , pathology , confidence interval , alternative medicine , environmental health

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom